Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neill J Liptrott

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
Advanced Drug Delivery Reviews|June 28, 2021
Drug delivery systems as immunomodulators for therapy of infectious disease: Relevance to COVID-19Danielle Brain, Alex Plant-Hately, Bethany Heaton, et al.
Antimicrobial Agents and Chemotherapy|November 2, 2016
Efavirenz Is Predicted To Accumulate in Brain Tissue: an In Silico, In Vitro, and In Vivo InvestigationPaul Curley, Rajith K R Rajoli, Darren M Moss, et al.
Nanomedicine (London, England)|July 24, 2014
Flow cytometric analysis of the physical and protein-binding characteristics of solid drug nanoparticle suspensionsNeill J Liptrott, Marco Giardiello, Joseph W Hunter, et al.
Drug Metabolism and Pharmacokinetics|June 21, 2018
Derivation of CYP3A4 and CYP2B6 degradation rate constants in primary human hepatocytes: A siRNA-silencing-based approachChristina Y S Chan, Owain Roberts, Rajith K R Rajoli, et al.
Journal of Materials Chemistry. B|April 9, 2020
High-throughput nanoprecipitation of the organic antimicrobial triclosan and enhancement of activity against Escherichia coliTom O McDonald, Lee M Tatham, Faye Y Southworth, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 23, 2022
Exposure of human immune cells, to the antiretrovirals efavirenz and lopinavir, leads to lower glucose uptake and altered bioenergetic cell profiles through interactions with SLC2A1Bethany J Heaton, Rebecca L Jensen, James Line, et al.
Pharmaceutics|November 26, 2022
Exposure of the Basophilic Cell Line KU812 to Liposomes Reveals Activation Profiles Associated with Potential Anaphylactic Responses Linked to Physico-Chemical CharacteristicsAlexander J Plant-Hately, Burcu Eryilmaz, Christopher A W David, et al.
Antimicrobial Agents and Chemotherapy|November 17, 2010
Raltegravir is a substrate for SLC22A6: a putative mechanism for the interaction between raltegravir and tenofovirDarren M Moss, Wai San Kwan, Neill J Liptrott, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 2, 2023
Umbilical cord mesenchymal stromal cell-derived extracellular vesicles lack the potency to immunomodulate human monocyte-derived macrophages in vitroTamiris Borges da Silva, Erika Rendra, Christopher A W David, et al.
Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology|October 1, 2019
Critical considerations for targeting colorectal liver metastases with nanotechnologyUsman Arshad, Paul A Sutton, Marianne B Ashford, et al.
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
Advanced Drug Delivery Reviews|June 28, 2021
Drug delivery systems as immunomodulators for therapy of infectious disease: Relevance to COVID-19Danielle Brain, Alex Plant-Hately, Bethany Heaton, et al.
Antimicrobial Agents and Chemotherapy|November 2, 2016
Efavirenz Is Predicted To Accumulate in Brain Tissue: an In Silico, In Vitro, and In Vivo InvestigationPaul Curley, Rajith K R Rajoli, Darren M Moss, et al.
Nanomedicine (London, England)|July 24, 2014
Flow cytometric analysis of the physical and protein-binding characteristics of solid drug nanoparticle suspensionsNeill J Liptrott, Marco Giardiello, Joseph W Hunter, et al.
Drug Metabolism and Pharmacokinetics|June 21, 2018
Derivation of CYP3A4 and CYP2B6 degradation rate constants in primary human hepatocytes: A siRNA-silencing-based approachChristina Y S Chan, Owain Roberts, Rajith K R Rajoli, et al.
Journal of Materials Chemistry. B|April 9, 2020
High-throughput nanoprecipitation of the organic antimicrobial triclosan and enhancement of activity against Escherichia coliTom O McDonald, Lee M Tatham, Faye Y Southworth, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 23, 2022
Exposure of human immune cells, to the antiretrovirals efavirenz and lopinavir, leads to lower glucose uptake and altered bioenergetic cell profiles through interactions with SLC2A1Bethany J Heaton, Rebecca L Jensen, James Line, et al.
Pharmaceutics|November 26, 2022
Exposure of the Basophilic Cell Line KU812 to Liposomes Reveals Activation Profiles Associated with Potential Anaphylactic Responses Linked to Physico-Chemical CharacteristicsAlexander J Plant-Hately, Burcu Eryilmaz, Christopher A W David, et al.
Antimicrobial Agents and Chemotherapy|November 17, 2010
Raltegravir is a substrate for SLC22A6: a putative mechanism for the interaction between raltegravir and tenofovirDarren M Moss, Wai San Kwan, Neill J Liptrott, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 2, 2023
Umbilical cord mesenchymal stromal cell-derived extracellular vesicles lack the potency to immunomodulate human monocyte-derived macrophages in vitroTamiris Borges da Silva, Erika Rendra, Christopher A W David, et al.
Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology|October 1, 2019
Critical considerations for targeting colorectal liver metastases with nanotechnologyUsman Arshad, Paul A Sutton, Marianne B Ashford, et al.
Pageof 5